Akèy › Kansè gastro-intestinal
Etid klinik pou Kansè gastro-intestinal ap rekrite nan Etazini
72 etid pou Kansè gastro-intestinal ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Houston, TX21 etid
- Boston, MA15 etid
- New York City, NY12 etid
- Nashville, TN10 etid
- Los Angeles, CA9 etid
- Durham, NC8 etid
- Dallas, TX8 etid
- Cincinnati, OH8 etid
- Baltimore, MD8 etid
- Arlington, VA8 etid
- San Antonio, TX7 etid
- Aurora, CO7 etid
- Seattle, WA7 etid
- St. Louis, MO6 etid
- Chicago, IL6 etid
- Washington, DC6 etid
- Grand Rapids, MI6 etid
- Baldwin Park, CA6 etid
- Philadelphia, PA6 etid
- San Francisco, CA5 etid
- Indianapolis, IN5 etid
- Atlanta, GA5 etid
- Queens, NY5 etid
- Tampa, FL5 etid
- Madison, WI4 etid
- Columbus, OH4 etid
- Rochester, MN4 etid
- Omaha, NE4 etid
- Sarasota, FL4 etid
- New Haven, CT4 etid
- Mountain View, CA4 etid
- Pittsburgh, PA4 etid
- Detroit, MI4 etid
- Phoenix, AZ4 etid
- Sacramento, CA4 etid
- Oklahoma City, OK4 etid
- Ann Arbor, MI4 etid
- San Diego, CA4 etid
- Salt Lake City, UT4 etid
- Santa Monica, CA3 etid
Pa eta
- Arizona8 etid
- Arkansas3 etid
- Colorado10 etid
- Connecticut5 etid
- Florid16 etid
- Georgia7 etid
- Illinois9 etid
- Indiana6 etid
- Iowa3 etid
- Kalifòni27 etid
- Kansas5 etid
- Lwizyàn3 etid
- Main3 etid
- Maryland14 etid
- Massachusetts15 etid
- Michigan13 etid
- Minnesota7 etid
- Missouri6 etid
- Nebraska5 etid
- New Jersey3 etid
- New Mexico3 etid
- New York14 etid
- North Carolina11 etid
- Ohio15 etid
- Oklahoma4 etid
- Oregon3 etid
- Pennsylvania9 etid
- South Carolina3 etid
- South Dakota3 etid
- Tennessee13 etid
- Texas26 etid
- Utah4 etid
- Virginia10 etid
- Washington8 etid
- Wisconsin8 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07529808Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07222800A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06663319A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07218926Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal, Gynecological, Breast, or Lung Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06855524DESTINY-PANTUMOUR04
Ap rekriteEtid obsèvasyon
Laj 18 a 130 · Tout sèks · Mizajou Sep 25, 2026 · NCT07124000Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06445062Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06128551Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05274048GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
Ap rekriteFaz 1 bonè
Laj 18 a 99 · Tout sèks · Mizajou Sep 18, 2026 · NCT07627191SURGE: Supporting Utility and Representation in Genomics-based Cancer Trial Enrollment (Intervention)
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT05375643Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06633224EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06263088Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT01313442Resilience and Equity in Aging, Cancer, and Health (REACH)
Ap rekrite
Laj 65 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT04674267Study to Assess the Efficacy and Safety of Rina-S in Participants With Advanced Gastrointestinal (GI) Cancers
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07539311Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT04899908Personalized Health Self-Management Training for Colorectal Cancer Survivors
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT05984589The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT04700527A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT06760819Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT07283939A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT05837767Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT06596694Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT06582017A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT07544589Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.